Fabry Disease Market Overview
Market Research Future (MRFR) asserts that the global Fabry disease market is anticipated to acquire the market value of USD 794.6 million, expanding at a CAGR of 6.8% during the review period from 2018 to 2023. The growing adoption of novel therapies like chaperone treatment is gaining prominence owing to its efficacy, which is projected to be a significant factor that can boost the Fabry disease market 2020. The increasing demand for messenger RNA (mRNA) as another efficient treatment method for Fabry disease is likely to favor the market growth during the forecast period. Various other factors like technological development in research practices and developing healthcare infrastructure are expected to be other causes that can enhance the demand for treatment and boost the market. On the contrary, lack of awareness about advanced methods and reluctance in the adoption of latest technologies are likely to hamper the market during the projection period. However, favorable reimbursement policies with aforementioned factors are predicted to counter the impeding factors, which can increase the demand and strengthen the market.
Get customized Sample with complete Toc, Inclusive of COVID-19 Industry Analysis @ https://www.marketresearchfuture.com/sample_request/7064
Fabry Disease Market Segmentation
The segmental analysis of the global Fabry disease market is done by diagnosis & treatment, type, and end-user.
The diagnosis & treatment-based segments of the global Fabry disease market are diagnosis and treatment. The diagnosis segment is further segmented into blood test, urine test, thyroid test, lung function test, and imaging. The imaging segment is segmented into echocardiogram, electrocardiogram (EKG), brain MRI, CT scan and others. The treatment segment is further segmented into gene therapy, enzyme replacement therapy, pharmaceutical formulations containing agalsidase alfa, anticonvulsants, analgesics, nonsteroidal anti-inflammatory drugs (NSAIDs), and others. Among all, the enzyme replacement therapy is expected to acquire the largest market share during the forecast period.
The type-based segments of the global Fabry disease market are type-1 and type-2. Among all, the type-2 Fabry disease is anticipated to acquire a major market share during the forecast period. The end-user-based segments of the global Fabry disease market are hospitals & clinics, diagnostic centres, research & academic institutes, and others.
Fabry Disease Market Regional Analysis
Based on the region, the global Fabry disease market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. As per the analysis, the global market is projected to dominate the market during the forecast period owing to the growing technological development and rising R&D initiatives. The developed economies like the US and Canada are anticipated to make significant market value during the review period.
Europe market is expected to acquire second largest market share during the projection period owing to the rising incidence of Fabry diseases. Countries like the UK and Germany are predicted to play a significant role in developing the regional market.
The APAC region is expected to be the fastest-developing regional market during the forecast period owing to the developing healthcare infrastructure. Besides, the presence of developing countries like India, Japan, and China are predicted to play a significant role by incorporating latest-technologies in healthcare sector.
The MEA region is anticipated to acquire the least market share during the forecast period owing to the presence of underdeveloped healthcare infrastructure. However, the Middle East countries are expected to strengthen the regional market owing to their economic stability.
Fabry Disease Market Key Players
The renowned players of the global Fabry disease market are Amicus Therapeutics, Inc., Amgen Inc., AVROBIO, Inc., Protalix, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd Idorsia Pharmaceuticals Ltd, GlaxoSmithKline, iBio, Inc., Novartis AG, Neuraltus Pharmaceuticals, Inc., Pfizer Inc., Shire, Sanofi, , and Takeda Pharmaceutical Company Limited.
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope Of The Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.4 Macroeconomic Indicators
4.5 Pipeline Products
Chapter 5. Market Factor Analysis
LIST OF TABLES
Table 1 Global Fabry Disease Market Synopsis, 2018–2023
Table 2 Global Fabry Disease Market Estimates And Forecast, 2018–2023 (USD Million)
Table 3 Global Fabry Disease Market, By Region, 2018–2023 (USD Million)
Table 4 Global Fabry Disease Market, By Type, 2018–2023 (USD Million)
Table 5 Global Fabry Disease Market, By Diagnosis & Treatment, 2018–2023 (USD Million)
Table 6 Global Fabry Disease Market, By End User, 2018–2023 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Market Structure For Global Fabry Disease Market
Figure 3 Market Dynamics For Global Fabry Disease Market
Figure 4 Global Fabry Disease Market Share, By Type, 2017
Figure 5 Global Fabry Disease Market Share, By Diagnosis & Treatment, 2017
Figure 6 Global Fabry Disease Market Share, By End User, 2017
Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @ https://www.marketresearchfuture.com/reports/fabry-disease-market-7064
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
+1 646 845 9312
NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.